查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
心臟定位市场规模、份额及成长分析（按类型、适应症、最终用户和地区划分）－2026-2033年产业预测
市场调查报告书
商品编码
1898039

心臟定位市场规模、份额及成长分析（按类型、适应症、最终用户和地区划分）－2026-2033年产业预测

Cardiac Mapping Market Size, Share, and Growth Analysis, By Type (Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems), By Indication (Atrial Fibrillation, Atrial Flutter), By End User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球心臟定位市场规模预计在 2024 年达到 21.6 亿美元，从 2025 年的 23.5 亿美元增长到 2033 年的 46.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.9%。

市场调查显示，美国约有1,400万人患有心律不整，这推动了对心臟定位系统的需求，使其成为先进的非侵入性解决方案。这项先进技术采集胸部电脉衝，并将其与电脑断层扫描数据结合，产生高品质的心臟标测图。这些精确的标测图对于专家分析心臟复杂的节律模式至关重要。心臟定位能够帮助医疗专业人员更深入地了解心律不整，从而实现更精准的诊断和个人化的治疗方案。这项创新不仅改善了患者照护，也使心臟定位成为心臟病学领域的重要工具，标誌着心臟健康管理领域的重要发展趋势。

全球心臟定位市场驱动因素

全球心臟定位市场的成长主要受两大关键因素驱动：心血管疾病发生率的不断上升以及心臟定位诊断技术的持续创新。心血管疾病是全球首要死因，每年夺走数百万人的生命，其中相当一部分是心臟病发作和中风造成的。这一令人担忧的趋势凸显了对先进诊断工具的迫切需求。随着医疗机构致力于改善患者预后，对先进心臟定位系统的需求持续增长，从而推动了这一重要领域的进一步发展和投资。

限制全球心臟定位市场发展的因素

影响全球心臟定位市场的主要限制因素之一是心臟影像影像程序日益复杂。随着心臟疾病诊断和治疗方法的不断完善，对先进技术和专业技能的需求也日益增长。这种复杂性可能会对医疗服务提供者造成障碍，尤其是在培训和资源分配方面，从而减缓心臟定位技术的广泛应用。此外，将这些先进程序整合到现有医疗系统中的复杂性可能导致成本增加，并可能对维持高效的工作流程构成挑战，从而阻碍市场成长。

全球心臟定位市场趋势

全球心臟定位市场正经历显着扩张，这主要得益于对先进心臟诊断技术日益增长的需求。医疗设备製造商的创新引领着这一趋势，不断提升心臟评估的准确性和效率。医护人员和患者对心臟健康的意识提升以及对精准检测技术的需求，进一步推动了这一发展趋势。此外，将先进的影像技术和人工智慧应用于心臟定位，有助于改善患者预后并提高手术效率。随着医疗系统将早期检测和个人化治疗置于优先地位，预计该市场在不久的将来将实现显着成长。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 监管环境

全球心臟定位市场规模（按类型和复合年增长率划分）（2026-2033 年）

  • 接触式心臟定位系统
  • 非接触式心臟定位系统

全球心臟定位市场规模（按适应症和复合年增长率划分）（2026-2033 年）

  • 心房颤动
  • 心房扑动
  • 房室结折返性心搏过速（AVNRT）
  • 其他迹象

全球心臟定位市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

  • 医院和诊所
  • 诊断中心
  • 其他最终用户

全球心臟定位市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Biosense Webster, Inc.（USA）
  • Abbott Laboratories（USA）
  • Boston Scientific Corporation（USA）
  • Medtronic plc（Ireland）
  • Acutus Medical, Inc.（USA）
  • AngioDynamics（USA）
  • Koninklijke Philips NV（Netherlands）
  • Biosig Technologies, Inc.（USA）
  • MicroPort Scientific Corporation（China）
  • Lepu Medical Technology（Beijing）Co., Ltd.（China）
  • Siemens Healthineers AG（Germany）
  • GE Healthcare（USA）
  • Johnson & Johnson（USA）
  • St. Jude Medical, Inc.（USA）
  • CardioInsight Technologies, Inc.（USA）
  • EP Solutions SA（Switzerland）
  • CathVision ApS（Denmark）
  • Acutus Medical, Inc.（USA）
  • MedLumics（Spain）

结论与建议

简介目录
Product Code: SQMIG35A2783

Global Cardiac Mapping Market size was valued at USD 2.16 Billion in 2024 and is poised to grow from USD 2.35 Billion in 2025 to USD 4.64 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

Market insights reveal that around 14 million people in the U.S. are affected by heart rhythm disorders, driving the growth of cardiac mapping systems as a sophisticated and non-invasive solution. This advanced technique collects electrical impulses from the chest, integrating them with data from computed tomography (CT) scans to produce high-quality cardiac maps. These intricate maps are essential for specialists as they analyze complex rhythm patterns of the heart. By utilizing cardiac mapping, healthcare professionals gain deeper insights into heart rhythm disorders, enabling more precise diagnoses and personalized treatment strategies. This innovation not only enhances patient care but also positions cardiac mapping as a critical tool in the realm of cardiology, signaling a significant trend in the management of heart health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Mapping Market Segments Analysis

Global Cardiac Mapping Market is segmented by Type, Indication, End User and region. Based on Type, the market is segmented into Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems. Based on Indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Mapping Market

The growth of the global cardiac mapping market is primarily driven by two significant factors: the increasing incidence of cardiovascular disorders and ongoing technological innovations in cardiac mapping diagnostics. Cardiovascular diseases are recognized as the primary cause of global mortality, leading to millions of deaths each year, with a considerable number of these fatalities resulting from heart attacks and strokes. This alarming trend highlights the urgent need for advanced diagnostic tools. As healthcare providers seek to improve patient outcomes, the demand for sophisticated cardiac mapping systems continues to rise, fostering further development and investment in this crucial sector.

Restraints in the Global Cardiac Mapping Market

One significant restraint influencing the Global Cardiac Mapping market is the growing complexity associated with cardiac imaging treatments. As the methodologies for diagnosing and managing cardiac conditions become more sophisticated, the need for advanced technologies and specialized skill sets intensifies. This complexity can create barriers for healthcare providers, particularly in terms of training and resource allocation, ultimately slowing down the widespread adoption of cardiac mapping techniques. Furthermore, the intricacies involved in integrating these advanced procedures into existing healthcare frameworks may lead to increased costs and potential challenges in maintaining streamlined workflows, thereby hindering market growth.

Market Trends of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is experiencing notable expansion, fueled by the rising demand for advanced cardiac diagnostic technologies. Innovations from medical device companies are at the forefront, enhancing the precision and efficiency of cardiac assessments. This trend is further propelled by an increasing awareness of cardiac health and the need for accurate testing methods among healthcare providers and patients alike. Additionally, the integration of advanced imaging techniques and artificial intelligence in cardiac mapping is driving improvements in patient outcomes and procedural efficiencies. As healthcare systems prioritize early detection and personalized treatment, the market is poised for significant growth in the foreseeable future.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Cardiac Mapping Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Contact Cardiac Mapping Systems
  • Non-Contact Cardiac Mapping Systems

Global Cardiac Mapping Market Size by Indication & CAGR (2026-2033)

  • Market Overview
  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
  • Other Indications

Global Cardiac Mapping Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals and Clinics
  • Diagnostic Centers
  • Other End Users

Global Cardiac Mapping Market Size & CAGR (2026-2033)

  • North America (Type, Indication, End User)
    • US
    • Canada
  • Europe (Type, Indication, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Indication, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Indication, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Indication, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Biosense Webster, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acutus Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosig Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology (Beijing) Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • St. Jude Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioInsight Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EP Solutions SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CathVision ApS (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acutus Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedLumics (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations